Sexual Agency of Women Who Have Suffered from Incest(s)
NCT ID: NCT06639542
Last Updated: 2024-10-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
10 participants
OBSERVATIONAL
2024-10-14
2025-04-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* The first meeting will be the presentation of a sexo-psychomotor questionnaire, specifically made for this study. Then, if the participant is willing, the enroll for a psychomotor follow-up of 6 sessions personalized with specific objectives defined for the patient,from the questionnaire.
* These therapy sessions can be renewed in discussion with the woman if we feel they would benefit from further follow-up. The psychomotor sessions last around 45 minutes and take place once every 15 days or 3 weeks with a variety of therapeutical techniques. This interval between sessions allows time for integration of the aspects addressed during the proposals, while ensuring continuity in the follow-up. They are aimed at developing body and emotional awareness, to help patients get to know themselves better, and experience moments in full awareness
* End-of-follow interview with taking the questionnaire a second time, to determine, with the woman, any benefits of the "sex-psychomotor" care. The women will be supported in completing the questionnaire again, as they were during the initial session.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Quantitative Study of Prevalence and Vulnerability Factors of Active Cyber Sexuality Among Teenagers in West Normandy
NCT03662321
Characteristics of Genealogical Representations of Perpetrators of Sexual Violence.
NCT05168956
Evaluation of the Care Path of Patients Who Have Been Sexually Assaulted
NCT04078789
Evaluation of the Impact of Participation in a Psycho-education Program for Victims of Sexual Violence
NCT06718387
Medico-legal Assessment of Sexual Violence-Assiut University
NCT05399563
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
7 Levels of sexual agency are described, with associated levels 4 and 5 (detailed and explained in the CRF document):
* Level 1 : Corporeality and self-presence. We'll be dealing with the participants' bodily sensations (sensory, tonic, etc.): exploring them, identifying them, naming them, and becoming aware of any associated thoughts and representations. The aim would be to validate and develop their physical and emotional awareness, identify what they do or don't want, and enable them to explore how to welcome their feelings.
* Level 2 : Sexual subjectivity. We will be working on the participants' self-definition regarding their gender and associated representations, their sexual and romantic orientation, and their experiences and feelings about their sexuality (sensations, emotions, representations, fantasies). The aim would be to enrich their body knowledge and representations (body schema and body image), to identify what is negative for them to distance themselves from it/protect themselves from it, and to clarify what is meaningful, positive, and beneficial for them to promote it.
* Level 3 : Affirmation and identity. Based on the activities, situations, or elements identified as positive/pleasant/appreciated by the participants in the previous levels, we seek to give value to their feelings, tastes, and choices, and to support their expression for themselves and others (especially intimate partners).
* Level 4 and 5 : Intimacy and relational and communicational skills. The aim will be to reinforce the interpersonal and communication skills of participants in their intimate time by identifying and expressing their needs as well as their partners. We want to increase their communication and empathy.
* Level 6 : Mutuality and play. We want to develop the playfulness of the participants to boost both the discovery between their partners and them during intimacy (not exclusively)
* Level 7 : Perspective of transcendence. For this last level, after all the work done previously, we want the participant to be spontaneous and independent about their agency.
These different levels build on each other and are rooted in women's physical and emotional experiences. In the questionnaire I suggest, levels 4 and 5 (Intimacy and Relational and Communicative Capacities) are combined for practical reasons, as the notions are particularly intertwined. Some aspects of these different levels may also overlap.
The questionnaire will be used as an initial assessment to determine more specific sex therapy goals based on each woman's sexual agency and to establish whether she wants to address her sexual agency after this assessment.
The different levels of agency in this questionnaire are assessed through different questions (from 2 to 10 questions depending on the level), which participants can answer using numerical scales from 1 to 10. The scales have been constructed in such a way that the lower the agency assessed, the lower the score. These different numerical values can then be added together to obtain an overall score for each level.
For instance, in the first level of sexual agency "Corporeality and self-presence", the highest score of agency will be 50.
However, some questions can't be answered with a numerical scale : The participant will have to color a figure or circle their emotions or answers, that couldn't have been relevant with a numerical scale. Some questions may be intrusive, the participants are free to tick the box "I am not concerned" or "I do not wish to answer". This answer will also be apprehended on a qualitative assessment.
An overall agency score will be determined by incorporating all the questions for which a quantitative assessment is possible, with a proportional coefficient for each level (the number of questions is not the same for each level). This overall score will be out of 60 points (10 points per level).
As it is not possible to score all the responses, I will carry out a qualitative and comparative analysis of the participants' responses for which numerical scoring is not possible.
If the participant is interested: set up a 6-session "sexo-psychomotor" follow-up based on the therapeutic objectives determined via the questionnaire.
The content of the sessions will not necessarily be the same from one patient to the other, as it is unlikely that all the women referred to us will have the same needs. Not all women will come to us with the same "background" and similar demands, which means that we need to adapt the support we offer.
To determine objectives and therapeutic proposals tailored to each patient, we will use the results of the questionnaire according to each theme or level of agency.
If some of the women assessed have a low level of sexual agency in level 1 (physicality and self-presence), we'll work on this axis first. Depending on their progress, we'll stay on this theme or move on to the next.
It should be noted that the limits between the different levels are permeable, the levels can overlap and the therapeutic objectives prepare and enrich the following ones. Finally, certain therapeutic mediations can be used to develop different levels of sexual agency, although the objectives to which they respond evolve in parallel with the participants' acquisition of a higher level of sexual agency.
Thus, the follow-up suggested in this study would have the particularity of moving towards sex-therapeutic objectives with psychomotor care and mediation (described above), hence the name "sex-psychomotricity".
Each session is divided into three parts:
* a first time of exchange (the participant's mood, expression of emotional or physical feelings, remarks in connection with the previous session(s), etc.).
* a second psycho-physical phase, using psychomotor mediation(s) (relaxation...).
* a third and final phase of verbalization/elaboration of what has been experienced during the mind-body session, with a link to the sexo therapy objectives and possible "infusion" into the field of sexuality.
End-of-care interview, with a second round of questionnaires, to determine, in discussion with the woman, any benefits of the "sex-psychomotor" care.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Women who have suffered from incest or rape
* Speak and understand French
Exclusion Criteria
* Non french-speakers
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier de Saint-Denis
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Maison des femmes
Saint-Denis, Seine Saint Denis, France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Emma FONT
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
N°IDRCB : 2024-A01594-43
Identifier Type: OTHER
Identifier Source: secondary_id
CHSD_0050_AFSI
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.